Nationwide Distribution including Puerto Rico and to the states of : CT, GA, NC, OK, NY, SC, KY, TN, CA, WA, OR, NJ, OH, PA, FL, MI, TX, WI, MO and NH.
Product Description
MicroScan Pos Combo Panel Type 33 (PC33): || Catalog number B1017-211 || MicroScan Pos Combo 33 B1017-211 panels are designed for use in determining quantitative and /or qualitative antimicrobial agent susceptibility and/or identification to the species level of colonies, grown on solid media, of rapidly growing || aerobic and facultative anaerobic gram-positive bacteria.
Worldwide Distribution: US (Nationwide) and to countries of: Argentina, Bahamas, Brazil, Canada, China, Ecuador, Egypt, Germany, Lithuania, Mexico, Paraguay, Peru Poland, Portugal, Romania, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thailand, Trinidad and Tobago, United Arab Emirates, Uruguay, and Venezuela.
Product Description
MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels || Containing Lower Imipenem Dilutions for Reporting CLSI M100-S20 || Breakpoints || Panel: ES¿L plus, Catalog B1027-101 || Microbiology: For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan panels are designed || for use in determining antimicrobial agent susceptibility and/or identification to the || species level of aerobic and facultatively anaerobic gram-negative bacilli.
Worldwide Distribution: US (Nationwide) and to countries of: Argentina, Bahamas, Brazil, Canada, China, Ecuador, Egypt, Germany, Lithuania, Mexico, Paraguay, Peru Poland, Portugal, Romania, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thailand, Trinidad and Tobago, United Arab Emirates, Uruguay, and Venezuela.
Product Description
MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels || Containing Lower Imipenem Dilutions for Reporting CLSI M100-S20 || Breakpoints || Panel: Neg MIC 38, Catalog B1017-412 || Microbiology: For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan panels are designed || for use in determining antimicrobial agent susceptibility and/or identification to the || species level of aerobic and facultatively anaerobic gram-negative bacilli.
Worldwide Distribution: US (Nationwide) and to countries of: Argentina, Bahamas, Brazil, Canada, China, Ecuador, Egypt, Germany, Lithuania, Mexico, Paraguay, Peru Poland, Portugal, Romania, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thailand, Trinidad and Tobago, United Arab Emirates, Uruguay, and Venezuela.
Product Description
MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels || Containing Lower Imipenem Dilutions for Reporting CLSI M100-S20 || Breakpoints || Panel: Neg/Urine Combo 61, Catalog B1017-414 || Microbiology: For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan panels are designed || for use in determining antimicrobial agent susceptibility and/or identification to the || species level of aerobic and facultatively anaerobic gram-negative bacilli.
Worldwide Distribution: US (Nationwide) and to countries of: Argentina, Bahamas, Brazil, Canada, China, Ecuador, Egypt, Germany, Lithuania, Mexico, Paraguay, Peru Poland, Portugal, Romania, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thailand, Trinidad and Tobago, United Arab Emirates, Uruguay, and Venezuela.
Product Description
MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels || Containing Lower Imipenem Dilutions for Reporting CLSI M100-S20 || Breakpoints || Panel: Neg/Urine Combo 55, Catalog B1017-409 || Microbiology: For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan panels are designed || for use in determining antimicrobial agent susceptibility and/or identification to the || species level of aerobic and facultatively anaerobic gram-negative bacilli.
Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.